VOYA Investment Management
BDTX icon

VOYA Investment Management’s Black Diamond Therapeutics BDTX Stock Holding History

VOYA Investment Management’s Portfolio BDTX Stock Details BDTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-11,518
Closed -$17.9K – 2657
2025
Q1 		$17.9K Sell
11,518
-808
-7% -$1.69K ﹤0.01% 2628
2024
Q4 		$26.4K Sell
12,326
-974
-7% -$2.79K ﹤0.01% 2725
2024
Q3 		$57.9K Buy
13,300
+407
+3% +$2.21K ﹤0.01% 2759
2024
Q2 		$60.1K Buy
+12,893
New +$69.2K ﹤0.01% 2774
2021
Q2 		– Sell
-8,290
Closed -$201K – 2813
2021
Q1 		$201K Buy
8,290
+512
+7% +$13.8K ﹤0.01% 2543
2020
Q4 		$249K Buy
+7,778
New +$256K ﹤0.01% 2301

Other funds holding BDTX

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

VOYA Investment Management's BDTX Position: Q2 2025 in Review

VOYA Investment Management sold out of Black Diamond Therapeutics (BDTX) in Q2 2025, closing a stake of 11,518 shares — an estimated $17.9K sold.

VOYA Investment Management first reported a position in BDTX in Q4 2020 and held it in 6 quarters. The position peaked at $249K in Q4 2020. 94 funds tracked by Wall St. Rank hold BDTX as of Q2 2025.

  • VOYA Investment Management reported no remaining Black Diamond Therapeutics position as of Q2 2025 after selling out during the quarter.
  • VOYA Investment Management sold 11,518 Black Diamond Therapeutics shares in Q2 2025, an estimated $17.9K.
  • VOYA Investment Management first reported a position in Black Diamond Therapeutics in Q4 2020 and held it in 6 quarters.
  • VOYA Investment Management's Black Diamond Therapeutics position peaked at $249K in Q4 2020.
  • 94 funds tracked by Wall St. Rank held Black Diamond Therapeutics as of Q2 2025.

Based on VOYA Investment Management's 13F filing for Q2 2025, filed 14 Aug 2025.